Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-033141)

Filing Details

Accession Number:: 0001209191-22-033141
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-01 16:13:24
Reporting Period:: 2022-05-27

Accepted Time:: 2022-06-01 16:13:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1435049	Chinook Therapeutics Inc.	KDNY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253170	Srinivas Akkaraju	C/O Chinook Therapeutics, Inc. 400 Fairview Avenue North, Suite 900 Seattle WA 98109		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-27	570,000	$14.00	5,161,888	No	4	P	Indirect	By Samsara BioCapital, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Samsara BioCapital, L.P.

Footnotes

Represents a purchase from the underwriters in a public offering of the issuer.
Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest therein.